Recherche
-
Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
(Plos Biology. vol. 18, n° 11, pp. e3000946, 2020-01-01)Article de revueLibre accès -
An intracytoplasmic B3 Leu718 deletion in a patient with a novel platelet phenotype
(Blood Adv.. vol. 1, n° 8, pp. 494–499, 2017)Article de revueAccès réservé -
Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
(Cardiovascular Diabetology. vol. 21, n° 1, pp. 71, 2022-05-09)Article de revueLibre accès -
Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study
(Critical Care. vol. 28, n° 1, pp. 54, 2024-02-20)Article de revueLibre accès -
Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study.
(Annals of Intensive Care. vol. 13, n° 1, pp. 94, 2023-09-29)Article de revueLibre accès -
Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes
(Diabetes care, 2021-12-01)Article de revue -
Management of liver failure in general intensive care unit
(Anaesthesia Critical Care & Pain Medicine. vol. 39, n° 1, pp. 143–161, 2020-04-09)Article de revueLibre accès -
Monitorage cardiovasculaire, vers des techniques sophistiquées moins invasives
(Oxymag. vol. 30, pp. 17 - 22, 2017-06-30)Article de revueLibre accès -
Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.
(American Journal of Hematology. vol. 90(6), pp. E127–129, 2015-06)Article de revueAccès réservé -
Overview of the current use of levosimendan in France: a prospective observational cohort study
(Annals of Intensive Care. vol. 13, n° 1, pp. 69, 2023-12)Article de revueLibre accès